Volume: 43 Issue: 1
Year: 2023, Page: 285-290, Doi: https://doi.org/10.51248/.v43i01.1884
Introduction and Aim: Hypertrophic cardiomyopathy (HCM) are the most common kind of cardiac disease that causes left ventricular asymmetric hypertrophy (LVH) or right ventricular hypertrophy (RVH) and non-dilated ventricular chambers. Heterozygous mutation in the MYH7 gene on chromosome 14 causes Left ventricular hypertrophy. The objective of our study was to unravel the mutation spectrum in HCM positive patients and find out novel mutation in MYH7 gene and the impact of these mutations on the pathophysiology of cardiac functioning.
Materials and Methods: Identification and confirmation of HCM patients was done on the basis of the thickness of the Interventricular septum and Left ventricular wall ( >13mm ; >15mm ). Extraction of DNA from the whole blood of HCM patients and healthy population using the standard phenol- chloroform extraction method was carried out. Polymerase Chain Reaction (PCR) was performed, and samples were processed for Sanger sequencing. Alter the structural arrangement and characteristics of respective mRNAs software’s RNA Fold Web server.
Results: We found a novel mutation in the MYH7 gene, which could cause phenotypic expressions similar to that of HCM.
Conclusion: Mutation in the gene may be responsible for causing hypertrophic cardiomyopathy. The mutations reported in our study, are responsible to alter the structural arrangement and characteristics of respective mRNAs.
Keywords: Left ventricular asymmetric hypertrophy; interventricular septum; echocardiography; left ventricular internal diameter.
1. Maron, B.J., McKenna, W. J., Danielson, G.K., Kappenberger, L.J., Kuhn, H.J., Seidman, C.E., et al., American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology committee for practice guidelines. Journal of the American College of Cardiology. 2003 Nov 5;42(9):1687-1713.
2. Maron, B.J., Towbin, J.A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., et al., Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006 Apr 11;113(14):1807-1816.
3. Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., et al., Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European heart journal. 2008 Jan 1;29(2):270-276.
4. Wigle, E.D., Sasson, Z., Henderson, M.A., Ruddy, T.D., Fulop, J., Rakowski, H., et al., Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Progress in cardiovascular diseases. 1985 Jul 1;28(1):1-83.
5. Spirito, P., Bellone, P., Harris, K.M., Bernabò, P., Bruzzi, P., Maron, B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. New England Journal of Medicine. 2000 Jun 15;342(24):1778-1785.
6. Curila, K., Benesova, L., Penicka, M., Minarik, M., Zemanek, D., Veselka, J., et al., Spectrum and clinical manifestations of mutations in genes responsible for hypertrophic cardiomyopathy. Acta cardiologica. 2012 Feb 1;67(1):23-29.
7. Marian, A.J., Modifier genes for hypertrophic cardiomyopathy. Current opinion in cardiology. 2002 May;17(3):242.
8. Kubo, T., Kitaoka, H., Okawa, M., Nishinaga, M., Doi, Y.L. Hypertrophic cardiomyopathy in the elderly. Geriatrics & gerontology international. 2010 Jan;10(1):9-16.
9. Biagini, E., Coccolo, F., Ferlito, M., Perugini, E., Rocchi, G., Bacchi-Reggiani, L., et al., Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. Journal of the American College of Cardiology. 2005 Oct 18;46(8):1543-1550.
10. Reant, P., Mirabel, M., Lloyd, G., Peyrou, J., Ayala, J.M., Dickie, S., et al., Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy. Heart. 2016 May 15;102(10):741-747.
11. Prajapati, D., Sharma, D., Baidya, S.G., Shakya, U., Shrestha, N. Normal echocardiographic parameters of healthy adult individuals working in National Heart Centre. Nepalese Heart Journal. 2012;9(1):3-6.
12. Arimura, T., Bos, J.M., Sato, A., Kubo, T., Okamoto, H., Nishi, H., et al., Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 2009 Jul 21;54(4):334-342.
13. Sambrook, H.C. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY. (No Title). 1989.
14. Lahiri, D.K., Nurnberger, J.I., A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic acids research. 1991 Oct 11;19(19):5444.
15. Bredt, D.S., Snyder, S.H. Nitric oxide: a physiologic messenger molecule. Annual review of biochemistry. 1994 Jul;63(1):175-195.
16. Nam, J.M., Lim, J.E., Ha, T.W., Oh, B., Kang, J.O. Cardiac-specific inactivation of Prdm16 affects cardiac conduction abnormalities and cardiomyopathy-associated phenotypes. American Journal of Physiology-Heart and Circulatory Physiology. 2020 Apr 1;318(4):H764-H777.
17. Arndt, A.K., Schafer, S., Drenckhahn, J.D., Sabeh, M.K., Plovie, E.R., Caliebe, A., et al., Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. The American Journal of Human Genetics. 2013 Jul 11;93(1):67-77.
18. Van Hoek, I., Hodgkiss‐Geere, H., Bode, E.F., Hamilton‐Elliott, J., Mõtsküla, P., Palermo, V., et al., Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy. Journal of Veterinary Internal Medicine. 2020 Mar;34(2):591-599.
19. Debonnaire, P., Joyce, E., Hiemstra, Y., Mertens, B.J., Atsma, D.E., Schalij, M.J., et al., Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation. Circulation: Arrhythmia and Electrophysiology. 2017 Feb;10(2): e004052.
20. Ozawa, K., Funabashi, N., Takaoka, H., Kamata, T., Kanaeda, A., Saito, M., et al., Characteristic myocardial strain identified in hypertrophic cardiomyopathy subjects
with preserved left ventricular ejection fraction using a novel multi-layer transthoracic echocardiography technique. International Journal of Cardiology. 2015 Apr 1;184:237-243.
21. Kübler, J., Burgstahler, C., Brendel, J.M., Gassenmaier, S., Hagen, F., Klingel, K., et al., Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy. The International Journal of Cardiovascular Imaging. 2021 Aug;37(8):2501-2515.
22. Singh, A., Singulane, C.C., Miyoshi, T., Prado, A.D., Addetia, K., Bellino, M., et al., Normal values of left atrial size and function and the impact of age: results of the world alliance societies of echocardiography study. Journal of the American Society of Echocardiography. 2022 Feb 1;35(2):154-164.
23. Doi, Y.L, Deanfield, J.E., McKenna, W.J., Dargie, H.J., Oakley, C.M., Goodwin, J.F. Echocardiographic differentiation of hypertensive heart disease and hypertrophic cardiomyopathy. Heart. 1980 Oct 1;44(4):395-400.
24. Spirito, P.A., Maron, B.J., Chiarella, F., Bellotti, P., Tramarin, R., Pozzoli, M., et al., Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy. Circulation. 1985 Aug;72(2):310-316.
25. Sanderson, J. E., Gibson, D.G., Brown, D.J., Goodwin, J. F. Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Heart. 1977 Jun 1; 39(6):661-670.
.
Padmapani A. Jagtap, Mosin A. Mansuri, Dnyaneshwar Rathod, Chandrakant B. Chavan, Varsha W. Wankhade, Phenotypic expressions of a novel mutation in the MYH7 gene responsible for hypertrophic cardiomyopathy in Pune population. Biomedicine: 2023; 43(1): 285-290